Full Text of SB1630 98th General Assembly
SB1630enr 98TH GENERAL ASSEMBLY |
| | SB1630 Enrolled | | LRB098 08625 MGM 38744 b |
|
| 1 | | AN ACT concerning regulation.
| 2 | | Be it enacted by the People of the State of Illinois,
| 3 | | represented in the General Assembly:
| 4 | | Section 5. The Medical Patient Rights Act is amended by | 5 | | adding Section 3.3 as follows: | 6 | | (410 ILCS 50/3.3 new) | 7 | | Sec. 3.3. Prohibition on the markup of anatomic pathology | 8 | | services. | 9 | | (a) A physician who orders, but who does not supervise or | 10 | | perform, an anatomic pathology service shall disclose in a bill | 11 | | for such service presented to the patient: | 12 | | (1) the name and address of the physician or laboratory
| 13 | | that provided the anatomic pathology service; and | 14 | | (2) the actual amount paid or to be paid for each | 15 | | anatomic pathology service provided to the patient by the | 16 | | physician or laboratory that performed the service. | 17 | | (b) A physician subject to the requirement of subsection | 18 | | (a) of this Section when billing a patient, insurer, or | 19 | | third-party payer shall not markup, or directly or indirectly | 20 | | increase, the amount subject to disclosure under paragraph (2) | 21 | | of subsection (a) of this Section in any bill presented to a | 22 | | patient, insurer, or third-party payer. | 23 | | (c) This Section does not prohibit a referring physician |
| | | SB1630 Enrolled | - 2 - | LRB098 08625 MGM 38744 b |
|
| 1 | | from charging a specimen acquisition or processing charge if: | 2 | | (1) the charge is limited to actual costs incurred for | 3 | | specimen collection and transportation; and | 4 | | (2) the charge is separately coded or denoted as a | 5 | | service distinct from the performance of the anatomic | 6 | | pathology service, in conformance with the coding policies | 7 | | of the American Medical Association. | 8 | | (d) The requirements of this Section do not apply to an | 9 | | anatomic pathology service ordered or provided by: | 10 | | (1) facilities licensed under the Hospital Licensing | 11 | | Act or the University of Illinois Hospital Act or clinical | 12 | | laboratories owned, operated by, or operated within | 13 | | facilities licensed under the Hospital Licensing Act or the | 14 | | University of Illinois Hospital Act; | 15 | | (2) any public health clinic or nonprofit health | 16 | | clinic; or | 17 | | (3) any government agency, or their specified public or | 18 | | private agents. | 19 | | (e) No patient, insurer, or other third-party payer, shall | 20 | | be required to reimburse any licensed health care professional | 21 | | for charges or claims submitted in violation of this Section. | 22 | | (f) A person who receives a bill for an anatomic pathology | 23 | | service made in knowing and willful violation of this Section | 24 | | may maintain an action to recover the actual amount paid for | 25 | | the bill. | 26 | | (g) The Department of Insurance shall enforce the |
| | | SB1630 Enrolled | - 3 - | LRB098 08625 MGM 38744 b |
|
| 1 | | provisions of this Section for any bill submitted to a payer in | 2 | | violation of this Section. | 3 | | (h) For the purposes of this Section, "anatomic pathology | 4 | | services" means: | 5 | | (1) histopathology or surgical pathology, meaning the | 6 | | gross and microscopic examination performed by a physician | 7 | | or under the supervision of a physician, including | 8 | | histologic processing; | 9 | | (2) cytopathology, meaning the microscopic examination | 10 | | of cells from (A) fluids, (B) aspirates, (C) washings, (D) | 11 | | brushings, or (E) smears, including the Pap smear test | 12 | | examination performed by a physician or under the | 13 | | supervision of a physician; | 14 | | (3) hematology, meaning the microscopic evaluation of | 15 | | bone marrow aspirates and biopsies performed by a | 16 | | physician, or under the supervision of a physician, and | 17 | | peripheral blood smears when the attending or treating | 18 | | physician or technologist requests that a blood smear be | 19 | | reviewed by a pathologist; | 20 | | (4) sub-cellular pathology or molecular pathology, | 21 | | meaning the assessment of a patient specimen for the | 22 | | detection, localization, measurement, or analysis of one | 23 | | or more protein or nucleic acid targets; and | 24 | | (5) blood-banking services performed by pathologists.
|
|